Jinmeiji Baicalin Capsules

1. Indications and Usage
Liver Disorders: Adjunctive treatment for acute, chronic, and persistent hepatitis.
2. Dosage and Administration
Adults: The usual dosage is 2 capsules (0.5 g) per dose, taken 3 times daily.
Administration: Taken orally with water.
3. Mechanism of Action
Antiviral Activity: The drug demonstrates significant inhibitory effects on hepatitis B surface antigen (HBsAg), e-antigen (HBeAg), and core antigen.
DNA Repression: It inhibits the replication of hepatitis B virus DNA (HBV-DNA).
Hepatoprotection: It significantly reduces alanine aminotransferase (ALT) levels and provides protective effects against liver damage.
4. Safety and Warnings
Contraindications: Contraindicated in patients with known hypersensitivity to Baicalin or any component of the formulation.
Precautions: Use with caution in pregnant women and those with a history of allergic reactions.
Integrity: Do not use if the appearance of the capsules has changed.
5. Adverse Reactions and Clinical Research
Safety Profile: There have been no reported cases of adverse reactions associated with this medication to date.
6. Drug Interactions
Chelation Effect: Concomitant use with medications containing magnesium, aluminum, or zinc may result in complexation, which can negatively affect drug absorption.
7. Pharmaceutical Information
Active Ingredient: Baicalin (Huangqin苷).
Chemical Formula: C21H18O11.
Strength: Typically 0.25 g per capsule.
Appearance: Hard capsules containing pale yellow granules or powder.
Storage: Store in a tightly closed, dry container.